Astrazeneca (AZN) Pension (2009 - 2026)
Astrazeneca (AZN) recorded quarterly Pension of -$953.0 million in Q1 2026, up 13.76% quarter-over-quarter from -$1.1 billion in Q4 2025, and up 25.49% on a YoY basis from -$759.4 million in Q1 2025.
Astrazeneca (AZN) Pension (2009 - 2026) Analysis & Trends
Astrazeneca's Pension history runs 18 years deep, the most recent figure standing at -$953.0 million for Q1 2026.
- In Q1 2026, Pension rose 25.49% year-over-year to -$953.0 million; the TTM figure through Mar 2026 stood at -$953.0 million (up 25.49% YoY), while the FY2025 annual figure was -$1.1 billion, down 183.08% from the prior year.
- Pension was -$953.0 million for Q1 2026 at Astrazeneca, up from -$1.1 billion in the prior quarter.
- In the past five years, Pension ranged from a high of $1.5 billion in Q4 2023 to a low of -$2.0 billion in Q1 2022.
- Historically, Pension has averaged -$791.1 million across 5 years, with a median of -$1.1 billion in 2023.
- The sharpest annual moves came in 2022 and 2025: Pension soared 62.47% in 2022, then plunged 183.08% in 2025.
- A 5-year view of Pension shows it stood at $1.2 billion in 2022, then jumped by 30.14% to $1.5 billion in 2023, then decreased by 12.5% to $1.3 billion in 2024, then sank by 183.08% to -$1.1 billion in 2025, then rose by 13.76% to -$953.0 million in 2026.
- The last three Pension figures came in at -$953.0 million (Q1 2026), -$1.1 billion (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Astrazeneca | 72.15 Bn | 64.21 Bn | 12.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -953.00 Mn |
| Dec 31, 2025 | -1.11 Bn |
| Sep 30, 2025 | -1.27 Bn |
| Jun 30, 2025 | -1.42 Bn |
| Mar 31, 2025 | -1.28 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 30, 2024 | -1.36 Bn |
| Jun 30, 2024 | -1.33 Bn |
| Mar 31, 2024 | -1.28 Bn |
| Dec 31, 2023 | 1.52 Bn |
| Sep 30, 2023 | -1.05 Bn |
| Jun 30, 2023 | -1.08 Bn |
| Mar 31, 2023 | -1.13 Bn |
| Dec 31, 2022 | 1.17 Bn |
| Sep 30, 2022 | -919.00 Mn |
| Jun 30, 2022 | -1.31 Bn |
| Mar 31, 2022 | -1.99 Bn |
| Dec 31, 2021 | 2.45 Bn |
| Sep 30, 2021 | -2.45 Bn |
| Jun 30, 2021 | -2.38 Bn |